144 related articles for article (PubMed ID: 10217333)
1. Plasma total phenytoin: a possibly misleading test in developing countries.
Fedler C; Stewart MJ
Ther Drug Monit; 1999 Apr; 21(2):155-60. PubMed ID: 10217333
[TBL] [Abstract][Full Text] [Related]
2. Serum albumin-adjusted phenytoin levels: an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countries.
Tandon M; Pandhi P; Garg SK; Prabhakar SK
Int J Clin Pharmacol Ther; 2004 Oct; 42(10):550-5. PubMed ID: 15516024
[TBL] [Abstract][Full Text] [Related]
3. Free phenytoin assessment in patients: measured versus calculated blood serum levels.
Tobler A; Hösli R; Mühlebach S; Huber A
Int J Clin Pharm; 2016 Apr; 38(2):303-9. PubMed ID: 26746902
[TBL] [Abstract][Full Text] [Related]
4. Estimating phenytoin concentrations by the Sheiner-Tozer method in adults with pronounced hypoalbuminemia.
Dager WE; Inciardi JF; Howe TL
Ann Pharmacother; 1995; 29(7-8):667-70. PubMed ID: 8520077
[TBL] [Abstract][Full Text] [Related]
5. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.
Hong JM; Choi YC; Kim WJ
Yonsei Med J; 2009 Aug; 50(4):517-20. PubMed ID: 19718399
[TBL] [Abstract][Full Text] [Related]
6. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
[TBL] [Abstract][Full Text] [Related]
7. Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.
Krasowski MD; Penrod LE
BMC Med Inform Decis Mak; 2012 Feb; 12():7. PubMed ID: 22333264
[TBL] [Abstract][Full Text] [Related]
8. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
9. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient.
Mlynarek ME; Peterson EL; Zarowitz BJ
Ann Pharmacother; 1996 Mar; 30(3):219-23. PubMed ID: 8833553
[TBL] [Abstract][Full Text] [Related]
10. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia.
Anderson GD; Pak C; Doane KW; Griffy KG; Temkin NR; Wilensky AJ; Winn HR
Ann Pharmacother; 1997 Mar; 31(3):279-84. PubMed ID: 9066931
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling.
Jun H; Rong Y; Yih C; Ho J; Cheng W; Kiang TKL
Drugs R D; 2020 Dec; 20(4):343-358. PubMed ID: 33026608
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.
Buckley MS; Reeves BA; Barletta JF; Bikin DS
Ann Pharmacother; 2016 Apr; 50(4):276-81. PubMed ID: 26783351
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of three methods for predicting concentrations of free phenytoin.
Beck DE; Farringer JA; Ravis WR; Robinson CA
Clin Pharm; 1987 Nov; 6(11):888-94. PubMed ID: 3677566
[TBL] [Abstract][Full Text] [Related]
15. Estimation of Free Phenytoin Concentration in Critically Ill Patients with Hypoalbuminemia: Direct-measurement vs Traditional Equations.
Wilfred PM; Mathew S; Chacko B; Prabha R; Mathew BS
Indian J Crit Care Med; 2022 Jun; 26(6):682-687. PubMed ID: 35836626
[TBL] [Abstract][Full Text] [Related]
16. Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia.
Javadi SS; Mahjub R; Taher A; Mohammadi Y; Mehrpooya M
Clin Pharmacol; 2018; 10():183-190. PubMed ID: 30588130
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin-oxacillin interactions in normal and uremic sera.
Dasgupta A; Sperelakis A; Mason A; Dean R
Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
[TBL] [Abstract][Full Text] [Related]
18. Interpatient and intrapatient variability in phenytoin protein binding.
Banh HL; Burton ME; Sperling MR
Ther Drug Monit; 2002 Jun; 24(3):379-85. PubMed ID: 12021629
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation.
Soriano VV; Tesoro EP; Kane SP
Ann Pharmacother; 2017 Aug; 51(8):669-674. PubMed ID: 28470115
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Review on the Predictive Performance of the Sheiner-Tozer and Derivative Equations for the Correction of Phenytoin Concentrations.
Kiang TK; Ensom MH
Ann Pharmacother; 2016 Apr; 50(4):311-25. PubMed ID: 26825643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
